Newsletter | August 20, 2025

08.20.25 -- As Billions Of Dollars Pour In, Do CDMO Valuations Matter?

SPONSOR

Webinar: Strategic Approaches to Controlled Release Formulation: Polymer Screening and Case Study Insights

Join Bend Bioscience for an insightful webinar on controlled release (CR) formulations—designed to optimize drug performance, enhance patient compliance, and reduce dosing frequency. Learn how to streamline CR development using efficient polymer screening methods and real-world case studies. Don’t miss this opportunity to gain actionable strategies and elevate your formulation expertise. Register now! Click here to learn more.

INDUSTRY INSIGHTS

Molecular Properties Of PROTACs And The Relationship To Formulation Design

Here, we conduct a comprehensive analysis of diverse PROTAC (Proteolysis Targeting Chimeras) structures, evaluating their calculated physicochemical properties to identify key trends.

Embracing Digital Transformation: A Path To Excellence

Discover how life science manufacturers are supported in digital transformation, offering solutions for automation, data integration, and compliance to optimize operations.

Early Solid Form Screening To Guide Drug Development

Conducting solid form screening early can help your team select and isolate the ideal lead polymorph to ensure manufacturability and stability while avoiding costs and hiccups down the road.

FEATURED EDITORIAL

As Billions Of Dollars Pour In, Do CDMO Valuations Matter?

Customers of a CDMO receiving some of the billions of dollars being invested in CDMOs might be enthusiastic. But large investment into the ownership pool can bring the ripple effects of transition. For some CDMO customers, this positively translates to increased offerings. For others, it introduces complexity and a shift in relationship dynamics. 

July 2025 — CDMO Opportunities And Threats Report

Each month, Outsourced Pharma works in conjunction with PharmSource, part of GlobalData, to present its “Contract Manufacturing: Opportunities and Threats (CMOT) Report” to our readers. The report identifies CDMOs that might be impacted by key events, including company acquisitions, product acquisitions and licenses, product approvals, late clinical product terminations, and FDA rejections.

INDUSTRY INSIGHTS CONTINUED

A Proven Approach To Impurity Control Across API And RSM Synthesis

To help manage impurities and mitigate risk across all stages of development, consider the benefits of working with a CDMO that has robust chemistry understanding and manufacturing experience.

Optimized Stability Storage

A healthcare manufacturer facing space constraints and regulatory pressures outsourced their stability storage needs to another company, resulting in reduced costs and focus on core competencies.

Form Fill And Seal Label Applicator For Drug Packaging

Discover a solution that, in terms of integration, is setting standards with a unique compact modular design for VFFS (Vertical Form Fill and Seal) and HFFS (Horizontal Form Fill and Seal) machines.

SOLUTIONS

Designed To Meet The Exterior Dimensions Of Glass Standard ISO 8362-1

Learn more about ready-to-use nested vials that meet the regulatory industry standards and offer broad compatibility with various fill/finish equipment available in the market.

Clinical Trial Services: Manufacturing, Packaging, Logistics, And Distribution

Explore the latest trends in sustainable living and guarantee the proper handling of your clinical materials to cover everything from warehousing and distribution to returns, collection, and destruction.

Global Advantage With Free Trade Zones In China

Understand how free trade zones work, and explore a flexible and cost efficient way to supply clinical trials in China and around the globe.

OUTSOURCED PHARMA CAPACITY UPDATE

Find Your New CDMO At Outsourced Pharma Capacity Update

CDMOs in biologics, cell and gene, and small molecule share their capabilities and available capacities. See for yourself why this virtual event has become a wildly popular resource to identify options for your development and manufacturing needs.

Connect With Outsourced Pharma: